Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
Q2 2025 Results Conference Call February 10, 2025 5:00 PM ETCompany ParticipantsMatt Gunter - Investor RelationsTim Danker ...
Royalty Pharma Plc (RPRX) reported its Q4 2024 earnings today, revealing earnings per share (EPS) of $0.3531, falling short of the forecasted $0.9849. The company also reported revenue of $594 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback